DNA Damage and Pulmonary Hypertension

Area of Science:

• Cardiovascular Research
• Genetics and Genomics
• Molecular Biology

Background:

• Pulmonary hypertension (PH) is defined by elevated mean pulmonary arterial pressure (>25 mmHg).
• Pulmonary arterial hypertension (PAH) involves distal pulmonary artery obstruction, endothelial dysfunction, and vascular proliferation, leading to right heart failure.
• Oxidative stress and inflammation are key factors in PAH progression, increasing DNA damage in vascular cells.

Purpose of the Study:

• To review evidence linking DNA damage and repair deficiencies to the pathogenesis of pulmonary arterial hypertension (PAH).
• To explore the role of impaired DNA repair mechanisms and associated protein expression in PAH vascular remodeling.

Main Methods:

• Review of recent scientific literature on DNA damage, DNA repair, and their association with PAH.
• Analysis of studies reporting DNA damage levels in PAH lungs, arteries, and animal models.
• Examination of research on DNA repair protein expression (BRCA1, TopBP1) in PAH.

Main Results:

• Elevated levels of DNA damage are observed in PAH lungs, remodeled arteries, and PH animal models.
• Impaired DNA repair mechanisms contribute to increased mutagen sensitivity in PAH patients.
• PAH is associated with decreased expression of genome integrity proteins BRCA1 and TopBP1.

Conclusions:

• DNA damage and deficient DNA repair pathways are significant contributors to PAH pathogenesis.
• These genomic instability factors promote the proliferative and apoptosis-resistant phenotype in PAH vascular cells.
• Further research into DNA repair mechanisms may reveal novel therapeutic targets for PAH.